A group of EU and US scientists claiming that low doses of the weed killer glyphosate "cause multiple types of cancer in rats ...

A Missouri appellate court has upheld a $611 million verdict awarded to three people who sued Bayer alleging that its Roundup weedkiller caused their cancer, a ruling the company says it will further ...

German agribusiness giant Bayer in April announced it filed a petition for writ of certiorari with the U.S. Supreme Court, ...

Standing by the side of Highway 63 with the Missouri state Capitol on the horizon, there’s a billboard that says, “Stand Up for Glyphosate.” Glyphosate is the key ingredient of Roundup, the flagship ...

In August of 2018, a California jury awarded a man $289 million in damages after he claimed using Roundup caused his cancer. Just a month earlier in July 2018, Bayer acquired Monsanto for $63 billion.

The future of Roundup, the world’s most widely used herbicide, hangs in the balance as chemical maker Bayer (OTCPK:BAYZF) (OTCPK:BAYRY) signals it may soon halt production unless it receives ...

Bayer was ordered by a jury in Georgia to pay about $2.1 billion to a plaintiff who claimed the company's Roundup weed killer caused his cancer, the plaintiff's law firms said on Friday.

Bayer AG saw its shares soar by 10% in early German trading following a crucial legal victory concerning its Roundup weedkiller. The surge came after a Philadelphia appeals court ruled in favor of ...

Bayer executives have been warning in recent weeks that after losing billions of dollars to Roundup case settlements and jury awards, they may be ready to give up the fight and get out of the ...

It was one of about 177,000 lawsuits to date filed against Bayer, which acquired Monsanto, the maker of the world’s most widely used weedkiller, in 2018. The company has set aside $16 billion to ...

She sued Roundup maker Monsanto in 2020 for failing to warn her that glyphosate, the active ingredient in Roundup, could cause cancer. Bayer AG, the German pharmaceutical conglomerate that owns ...

A bill that would have insulated Bayer and other chemical companies from lawsuits over cancer risks failed in the Missouri Senate, after bipartisan opposition arose. But there's little doubt that ...